Search

Your search keyword '"Scales, S"' showing total 73 results

Search Constraints

Start Over You searched for: Author "Scales, S" Remove constraint Author: "Scales, S"
73 results on '"Scales, S"'

Search Results

3. Overview of the JET results with the ITER-like wall

4. Overview of the JET results with the ITER-like wall

5. Overview of JET results

7. Overview of JET results

12. AN ANIMAL MODEL FOR HUMAN BREAST CARCINOMA

13. A discontinuous SNAP-25 C-terminal coil supports exocytosis.

14. Membrane recruitment of coatomer and binding to dilysine signals are separate events.

15. A formiminotransferase cyclodeaminase isoform is localized to the Golgi complex and can mediate interaction of trans-Golgi network-derived vesicles with microtubules.

20. Overview of JET results

22. Discovery of Highly Selective Inhibitors of Microtubule-Associated Serine/Threonine Kinase-like (MASTL).

23. A Disconnection for Rapid Access to Heterocyclic Benzylic Amines with Fully Substituted α-Carbons.

24. Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome.

25. Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes.

26. Genetic dissection of triplicated chromosome 21 orthologs yields varying skeletal traits in Down syndrome model mice.

27. SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance.

28. Energy cost and knee extensor strength changes following multiple day military load carriage.

29. Comprehensive phenotypic analysis of the Dp1Tyb mouse strain reveals a broad range of Down syndrome-related phenotypes.

30. Exploring the role of effective nurse leadership during COVID-19.

31. Development of a Late-Stage Diversification Strategy for the 4- and 5-Positions of 4,5,6-Trisubstituted Indazoles.

33. Interaction of sexual dimorphism and gene dosage imbalance in skeletal deficits associated with Down syndrome.

34. Rhodium(III)-Catalyzed C-H Activation: Ligand-Controlled Regioselective Synthesis of 4-Methyl-Substituted Dihydroisoquinolones.

35. Gene expression dysregulation domains are not a specific feature of Down syndrome.

36. Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain.

37. Analysis of motor dysfunction in Down Syndrome reveals motor neuron degeneration.

38. Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models.

39. Correction to Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors.

40. Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors.

41. Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel.

42. Synthesis of Small 3-Fluoro- and 3,3-Difluoropyrrolidines Using Azomethine Ylide Chemistry.

43. Alterations to dendritic spine morphology, but not dendrite patterning, of cortical projection neurons in Tc1 and Ts1Rhr mouse models of Down syndrome.

44. Studies on the regioselective nucleophilic aromatic substitution (S(N)Ar) reaction of 2-substituted 3,5-dichloropyrazines.

45. Identification of novel pyrrolopyrazoles as protein kinase C β II inhibitors.

46. Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model.

47. The ionic layer is required for efficient dissociation of the SNARE complex by alpha-SNAP and NSF.

48. Cell biology. Fusion without SNAREs?

49. Calcium regulation of exocytosis in PC12 cells.

50. Sequential SNARE assembly underlies priming and triggering of exocytosis.

Catalog

Books, media, physical & digital resources